Dr. Jiexin Huan | Biomechanical Validation | Best Researcher Award

Dr. Jiexin Huan | Biomechanical Validation | Best Researcher Award

Associate Chief Physician, at Nanping First Hospital Affiliated to Fujian Medical University, China.

Jiexin Huang is an Associate Chief Physician at Nanping First Hospital Affiliated to Fujian Medical University. He specializes in joints, sports medicine, acetabular and pelvic fractures, and bone tumors.

Professional Profile

Scopus

๐ŸŽ“ Education

– Medical Education, China Medical University’s First Hospital

๐Ÿ’ผ Experience

– *Associate Chief Physician*, Nanping First Hospital Affiliated to Fujian Medical University- *Research Projects*: led multiple research projects funded by Nanping, Fujian Medical University, and Fujian’s Natural Science Fund

๐Ÿ”ฌ Research Interests

– *Joints and Sports Medicine*: biomechanics and clinical applications of novel anatomical titanium plates for acetabular fractures- *Bone Tumors*: investigating the role of NGF-P75NTR in neurogenic arthritis- *Orthopedic Surgery*: decision-making in hip arthroplasty and treatment of fractures

๐Ÿ† Awards

– *Awards in Orthopedic Competitions*: recognized for contributions to orthopedic surgery- *Patents*: published or in the process of publishing three patents related to orthopedic devices and systems

๐Ÿ“š Top Noted Publications

– Decision-making analysis of hip arthroplasty following failed internal fixation of intertrochanteric fractures in the elderly ๐Ÿฅ
– Published in Orthop Surg
– Treatment of acetabular anterior column fractures with posterior hemi-transverse component using anatomical titanium plates ๐Ÿฉบ
– Published in J Orthop Surg Res
– Wireless charging optogenetic components for medical devices ๐Ÿ’ก
– Published in Small Methods
– Role of NGF-P75NTR in regulating the NF-ฮบB pathway in myeloid cells in neurogenic arthritis ๐Ÿ”ฌ
– Published in Front Cell Infect Microbiol
– Biomechanical study of H-shaped anatomical titanium plate for acetabular fractures ๐Ÿฆด
– Published in indexed journals
– Finite element analysis of novel H-shaped anatomical titanium plate for acetabular fractures ๐Ÿ’ป
– Published in indexed journals
– Biomechanical and clinical comparative study of third-generation sacroiliac joint locking plate ๐Ÿ“Š
– Published in indexed journals
– Other publications: 2 more articles published in indexed journals

Conclusion

Jiexin Huang’s research productivity, leadership in research projects, and clinical and research expertise make him a strong candidate for the Best Researcher Award. With further interdisciplinary collaboration and industry partnerships, he could further enhance the impact of his research and contribute to advancements in orthopedic surgery.

Prof. Dr. Emiliano Schena | Bio-Mechanics | Outstanding Scientist Award

Prof. Dr. Emiliano Schena | Bio-Mechanics | Outstanding Scientist Award

Professore Ordinario, Universitร  Campus Bio-Medico di Roma, Italy

๐Ÿง‘โ€๐ŸŽ“ Dr. Paola Saccomandi is a Full Professor at the School of Engineering, Universitร  Campus Bio-Medico di Roma (UCBM), Italy. Her research focuses on wearable systems, sensor design, and thermal treatment for cancer removal.

Profile

scholar

๐ŸŽ“ Education

Ph.D. in Biomedical Engineering, Universitร  Campus Bio-Medico di Roma (UCBM), Italy, 2009๐Ÿ“š *Laurea Magistrale Degree (MS) in Biomedical Engineering*, UCBM, Italy, 2006๐Ÿ“š *Laurea Degree (BSc) in Biomedical Engineering*, UCBM, Italy, 2003

๐Ÿ‘จโ€๐Ÿ”ฌ Experience

*Full Professor*, School of Engineering, UCBM, Italy, 2022-present๐ŸŒŸ *Adjunct Professor*, School of Engineering, Arkansas University Program in Rome, Italy, 2025-present๐Ÿ”ฌ *Researcher*, Fondazione Policlinico Universitario Campus Bio-Medico, Rome, Italy, 2023-present๐Ÿ“š *Scientific Responsible of UCBM Academy*, UCBM, Italy, 2024-present

๐Ÿ” Research Interest

*Wearable systems* for monitoring physiological parameters๐Ÿ” *Sensor design* for medical applications๐Ÿ” *Thermal treatment* for cancer remoDr. Paola Saccomandi is a strong candidate for the Best Researcher Award, given her impressive record of interdisciplinary research, innovative contributions, and international collaborations. Her dedication to education and mentorship is also commendable. With some additional focus on translational research and public engagement, Dr. Saccomandi has the potential to make even more significant impacts in her field.val

Awards and Honors๐Ÿ†

– ERC Starting Grant, LASER OPTIMAL project

๐Ÿ“š Publicationsย 

1. NOTCH2NLC GGC intermediate repeat with serine induces hypermyelination and early Parkinson’s disease-like phenotypes in mice.
2. The Effects of Extrinsic and Intrinsic Factors on Neurogenesis.
3. Spatially informed clustering, integration, and deconvolution of spatial transcriptomics with GraphST.
4. Single-cell transcriptomics and surface epitope detection in human brain epileptic lesions identifies pro-inflammatory signaling.
5. APP Intracellular Domain Promotes Expression of LRRK2 Enabling a Feed-Forward Loop of Neurodegeneration in Parkinsonโ€™s Disease

6. Laser Ablation: SElectivity and monitoRing for OPTImal tuMor removal- LASER OPTIMAL
7. Measurements of gas flow and thermo-hygrometric conditions in mechanical ventilation
8. Theoretical model and design of a device to reduce the influence of environmental factors on refractive surgery outcomes
9. Contrast analysis of x-ray radiographic images

Conclusion

Dr. Paola Saccomandi is a strong candidate for the Best Researcher Award, given her impressive record of interdisciplinary research, innovative contributions, and international collaborations. Her dedication to education and mentorship is also commendable. With some additional focus on translational research and public engagement, Dr. Saccomandi has the potential to make even more significant impacts in her field.

Pedro Villarego | Bio-Mechanics | Best Researcher Award

Assoc Prof Dr. Pedro Villarego | Bio-Mechanics | Best Researcher Award

Associate Chief of Surgery at Fundaciรณn Jimรฉnez Dรญaz University Hospital, Spain

Assoc Prof Dr. Pedro Villarego is an accomplished medical professional with over 21 years of specialized experience in surgery. He currently serves as the Associate Chief and coordinator of several surgical units at Fundaciรณn Jimรฉnez Dรญaz University Hospital. ๐Ÿฉบ His expertise spans peritoneal oncologic surgery, hepatobiliary surgery, endocrine surgery, and breast pathology. ย He earned his medical degree from the University of Cรณrdoba and a Ph.D. in Medicine and Surgery from the University of Mรกlaga. He has made significant contributions to cancer care, including the establishment of the first Intraperitoneal Chemohyperthermia Unit in Castilla-La Mancha. ย Assoc Prof Dr. Pedro Villaregois also recognized for his teaching roles at the Autonomous University of Madrid and has supervised numerous doctoral theses.

Publication Profile

Educationย  ๐ŸŽ“

Assoc Prof Dr. Pedro Villarego completed his Bachelorโ€™s degree in Medicine at the University of Cรณrdoba in 1995. ๐Ÿฉบ He later earned an Official Specialist Title in General Surgery and Digestive System from the 12 de Octubre University Hospital in 2004. ๐Ÿ“š His academic journey culminated with a Ph.D. in Medicine and Surgery from the University of Mรกlaga in 2011, where he defended his doctoral thesis on VEGF and VEGFC levels in gastric cancer. ๐ŸŽ–๏ธ Assoc Prof Dr. Pedro Villarego holds two master’s degrees: one in Medical Management and Clinical Management from UNED (2008-2009) and another in Sarcomas and Musculoskeletal Tumors from the European University of Madrid (2021-2022). ๐Ÿ“– His academic excellence is reflected in his outstanding Cum Laude honors and ongoing dedication to surgical research.

Experience ๐Ÿฅย 

Assoc Prof Dr. Pedro Villaregohas over two decades of specialized surgical experience. He secured a permanent statutory position at Castilla-La Mancha Health Service’s Ciudad Real University Hospital in 2008. ๐Ÿ’ผ Currently, he serves as the Associate Chief at Fundaciรณn Jimรฉnez Dรญaz University Hospital, coordinating several high-profile units, including Peritoneal Oncologic Surgery and Hepatobiliary Surgery. ๐Ÿ‘ฉโ€๐Ÿซ Since 2022, Dr. [Name] has been an Associate Professor at the Autonomous University of Madrid, where he teaches surgery and biomedical engineering. ๐Ÿ“š His teaching experience also extends to the University of Castilla-La Mancha, where he served from 2013 to 2018. ๐ŸŽ“ He has supervised 5 doctoral theses and 8 undergraduate projects, contributing extensively to surgical education and research.

Awards and Honors ๐Ÿ…

Assoc Prof Dr. Pedro Villarego has been the recipient of several prestigious awards. In 2013, he received the gold badge of AMUMA for his pioneering work in ovarian cancer care and establishing the first Intraperitoneal Chemohyperthermia Unit in Castilla-La Mancha. ๐ŸŒŸ His dedication to research was recognized in 2020 when he won the National Research Intensification Award from the Quironsalud Group. ๐Ÿ† Assoc Prof Dr. Pedro Villarego has been honored for his innovative contributions to cancer treatment, particularly in surgical oncology and multidisciplinary approaches to patient care. ๐Ÿ… His efforts have made a significant impact on both clinical practices and surgical research in Spain, earning him national recognition. ๐Ÿ“– Additionally, his research in oncologic surgery has garnered awards for excellence in medical advancement.

Research Focus ๐Ÿ”ฌ

Assoc Prof Dr. Pedro Villarego focuses his research on surgical oncology, particularly peritoneal oncologic surgery and the role of VEGF/VEGFC in gastric cancer recurrence and mortality. ๐Ÿ’‰ He is dedicated to improving outcomes for cancer patients through innovations in fiber optic sensing, hyperthermic intraperitoneal chemotherapy (HIPEC), and minimally invasive surgical techniques. ๐Ÿฉบ His research also explores hepatobiliary and endocrine surgery, as well as breast pathology, aiming to integrate advanced technologies into surgical practices. ๐Ÿ“š Assoc Prof Dr. Pedro Villarego has contributed to over 15 national and provincial projects and holds multiple patents in his field. ๐Ÿ“– His work extends to international collaborations on cancer treatment protocols and he is particularly interested in translational research that bridges clinical applications with scientific discovery.

Publicationย  Top Notes

Intraperitoneal administration of carcinoembryonic antigen-directed CAR T cells for peritoneal carcinomatosis in colorectal cancer โ€“ Cytotherapy (2024)ใ€DOI: 10.1016/J.JCYT.2023.10.007ใ€‘.

Paclitaxel as HIPEC drug for ovarian peritoneal metastases โ€“ Current Oncology (2024)ใ€DOI: 10.3390/CURRONCOL31020048ใ€‘.

POTEE induces invadopodia formation in breast cancer cells โ€“ Molecular Oncology (2024)ใ€DOI: 10.1002/1878-0261.13568ใ€‘.

Non-invasive estimation of PCI in colorectal peritoneal carcinomatosis โ€“ Cirugรญa Espaรฑola (2024)ใ€DOI: 10.1016/J.CIRENG.2022.03.021ใ€‘.

Long-term intraperitoneal access with new catheter design โ€“ Journal of Surgical Oncology (2024)ใ€DOI: 10.1002/jso.27843ใ€‘.

Pseudomyxoma peritonei: No systemic dissemination with undetectable ctDNA โ€“ European Journal of Surgical Oncology (2024)ใ€DOI: 10.1016/j.ejso.2024.108395ใ€‘.

Efficacy and safety of HIPEC in colon cancer โ€“ JAMA Surgery (2023)ใ€DOI: 10.1001/JAMASURG.2023.0662ใ€‘.

First trial of CEB-01 for retroperitoneal sarcoma โ€“ Annals of Oncology (2023)ใ€DOI: 10.1016/J.ANNONC.2023.09.1161ใ€‘.

Adipose-derived mesenchymal stem cells in abdominal sepsis โ€“ Stem Cell Research & Therapy (2023)ใ€DOI: 10.1186/S13287-023-03588-Xใ€‘.

Mucin analysis in pseudomyxoma peritonei โ€“ Journal of Clinical Medicine (2023)ใ€DOI: 10.3390/JCM12124007ใ€‘.

Conclusion

Given the individualโ€™s significant contributions to the fields of surgical oncology, clinical management, research, and education, they are a highly deserving candidate for the Best Researcher Award. Their achievements in establishing innovative cancer treatment methods, combined with their leadership in both medical practice and academic spheres, highlight their outstanding qualifications. Expanding their international research presence and publication record could further enhance their already impressive profile for future recognition.